Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine plus bupivacaine versus bupivacaine alone for elective cesarean delivery under spinal anesthesia
IRCT20181107041590N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain and Perioperative cardiovascular instability (PCVI) comparing Dexmedetomidine plus bupivacaine with Bupivacaine plus saline control (2 arms). Primary endpoints: Maternal hemodynamic parameters, Maternal pain and 2 more. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative painPerioperative cardiovascular instability (PCVI)
Beyond the preview
Go deeper on IRCT20181107041590N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181107041590N1.